DEVIN SMITH: Open Payments
NPI 1407575830 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,708 in 92 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $794 · 2025 $1,708
Food & beverage: $1,619Education: $89
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 10 | $235 |
| Amgen Inc. | 11 | $220 |
| BridgeBio Pharma, Inc. | 3 | $161 |
| Merck Sharp & Dohme LLC | 10 | $158 |
| E.R. Squibb & Sons, L.L.C. | 16 | $147 |
| Novo Nordisk Inc | 7 | $145 |
| Alnylam Pharmaceuticals Inc. | 6 | $107 |
| United Therapeutics Corporation | 4 | $92 |
| Providence Medical Technology, Inc. | 1 | $87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $62 |
Products named: REPATHA, OPSUMIT, Attruby, Wegovy, VERQUVO, Tyvaso, ELIQUIS, AMVUTTRA.
Industry payments across NC — which companies pay providers there.
